AN anti-cancer drug extracted from cow urine and developed by Gau Vigyan Anusandhan Kendra of Nagpur got a third US patent for its anti-genotoxicity properties. The same extract, developed by the Kendra had earlier got the US patent as a bio-enhancer with antibiotics and anti-cancer drugs.
Research for the drug, whose brand name is Kamdhenu Ark was carried out jointly by the Kendra and National Environmental Engineer Research Institute (NEERI), said Shri Tapan Chakraborty, acting director of the NEERI, while giving details of the patent received recently.
Shri Chakraborty and Shri Sunil Mansinghka of the Kendra told media persons in Nagpur that the research found that Re-distilled Cow Urine Distillate (RCUD) was useful for protecting and repairing DNA from oxidative damage. They said the oxidative DNA damage is a leading cause of ageing, cancer and other diseases. RCUD works against genotoxicity, a harmful action on a cell’s genetic material, they said, adding that research has strengthened the efficacy of Kamdhenu Ark as anti-cancer drug.
The research was carried out on some patients having throat and uterus cancer, Shri Mansinghka said. More details on cow related products of the Kendra can be found in the following link www.govigyan.com/medicalproducts.html.
(FOC)
